Alkermes (ALKS)
(Delayed Data from NSDQ)
$28.55 USD
+0.68 (2.44%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $28.55 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Alkermes plc has a PEG ratio of 0.94 compared to the Medical - Biomedical and Genetics industry's PEG ratio of 1.64.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ALKS 28.55 +0.68(2.44%)
Will ALKS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ALKS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALKS
Immunovant (IMVT) Up 7.8% Since Last Earnings Report: Can It Continue?
Krystal Biotech (KRYS) Up 8.5% Since Last Earnings Report: Can It Continue?
ALKS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Is Alkermes (ALKS) Up 4.7% Since Last Earnings Report?
Alkermes Q2 Earnings Beat Estimates, Proprietary Drugs Aid Sales
Alkermes (ALKS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Other News for ALKS
ALKS forms 50 Day Moving Average Resistance on September 17
Is ALKS building bearish momentum? Lower Bollinger Band Walk shows up after advancing 3.28%
IYH: Healthcare Dashboard For September
ALKS forms NR7 on September 15
Tracking Baker Brothers Portfolio - Q2 2025 Update